Recently, autocrine FGFR activation has been correlated with HES1 (hairy and enhancer of split-1) expression and AKT-dependent cell proliferation in endometrial cancers insensitive to Notch inhibition [89]. The gene discussed is HES1; the disease is endometrial cancer.